Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| ST1-R52D3 | Rat | Rat STEAP1 Protein, Flag,His Tag (Detergent) |  |
|
|
| ST1-H82D3 | Human | Biotinylated Human STEAP1 Full Length Protein, Avitag™,Flag&His Tag (Detergent) |  |
|
|
| CHEK-ATP154 | Human | HEK293/Human STEAP1 Stable Cell Line | |||
| ST1-H5283 | Human | Human STEAP1 Full Length Protein, Twin-Strep,His Tag (Detergent) (SPR verified) |  |
|
|
| SCCHO-ATP121 | Human | CHO/Human STEAP1 Stable Cell Line |
Expression analysis of human STEAP1 on HEK293/Human STEAP1 Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human STEAP1 Stable Cell Line or negative control cell using anti-human STEAP1 antibody followed by staining with PE anti-human IgG Fc Antibody.
Expression analysis of human STEAP1 on CHO/Human STEAP1 Stable Cell Line by FACS.
Cell surface staining was performed on CHO/Human STEAP1 Stable Cell Line or negative control cell using anti-human STEAP1 antibody followed by staining with PE anti-human IgG Fc Antibody.
Anti-STEAP1 Antibody captured on Protein A Chip can bind Biotinylated Human STEAP1 Full Length Protein, Avitag,Flag&His Tag (Cat. No. ST1-H82D3) with an affinity constant of 12.8 nM as determined in a SPR assay (in presence of DDM and CHS) (Biacore 8K) (Routinely tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Xaluritamig | AMG-509 | Phase 3 Clinical | Xencor Inc, Amgen Inc | Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms; Castration-Sensitive Prostate Neoplasms | Details |
| 89Zr-DFO-MSTP2109A | Phase 2 Clinical | Memorial Sloan Kettering Cancer Center, Genentech Inc | Prostatic Neoplasms | Details | |
| STEAP1 CART Cell Therapy(PromiCell) | Phase 2 Clinical | PromiCell Therapeutics Inc, Fred Hutchinson Cancer Research Center | Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms | Details | |
| ABBV-969 | ABBV-969; ABBV969 | Phase 1 Clinical | Abbvie Inc | Prostatic Neoplasms, Castration-Resistant | Details |
| ADRX-0405 | ADRX-0405 | Phase 1 Clinical | Adcentrx Therapeutics Inc | Solid tumours; Neoplasms | Details |
This web search service is supported by Google Inc.
A-Z
